79
56
Growth Score 79 in past quarter
-9 pts
Heat Score 56 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4130715
Osteologix is engaged in late stage development of pharmaceutical products for diseases of bone and cartilage.
About the Company
Osteologix is engaged in late stage development of pharmaceutical products for diseases of bone and cartilage.
Osteologix is committed to developing innovative pharmaceuticals for the treatment and prevention of diseases of bone and joint tissues. It is our vision to improve the health of those afflicted with musckuloskelatal diseases such as
osteoporosis.
Our Mission is to partner with the healthcare community to apply new scientific information and clinical data to the development of products that improve patient care in a safe and ethical manner.